Pharmacy News

Subscribe to Pharmacy News feed
PharmaTimes - The latest news in healthcare and life sciences - News RSS
Updated: 31 min 20 sec ago

A category to cover all areas within medical affairs in MSEA 2019

The categories in the Medical & Scientific Excellence Awards have been expertly designed to accurately reflect the current medical affairs environment.

European Commission grants orphan status to nirogacestat

The drug is being developed for the treatment of soft tissue sarcoma

CR UK kicks off entrepreneurship initiative

The programme strives to promote the development of new business ventures within academia

University opens new earlier diagnosis institute

The Sir James Mackenzie Institute for Early Diagnosis Information is an international collaboration striving to secure earlier disease detection

UK to invest in research on evolving global health threats

Chief medical officer Professor Dame Sally Davies announced funding for two projects

Evotec links with Takeda

The companies aim to establish five new drug discovery programmes

GW's cannabinoid Epidyolex wins EU approval

NICE rejected NHS funding for the drug in August

MHRA clarifies position on off-label Avastin

Roche's drug has been used for years to treat wet AMD, an indication for which it is not specifically licensed

Gov't announces 'no deal' protection for UK nationals in EU

Under the plans, people already living in the EU who have their healthcare funded by the UK will have their healthcare costs covered for six months

Tickets available for the 2019 Marketer of the Year gala dinner and awards ceremony

This year’s awards ceremony will be taking place at the Chelsea Harbour Hotel on the 14th November.

EU nod for Bayer's Vitrakvi

European regulators have cleared Bayer's Vitrakvi (larotrectinib) as a treatment for solid tumours displaying an NTRK gene fusion.

NICE calls for further research on tinnitus management

Healthcare professionals should develop a management plan with the patient

Hospital admissions increase 28% in ten years

The figures should serve as a "wake-up call', says the BMJ.

Bluebird reveals positive gene therapy data

The therapy targets cerebral adrenoleukodystrophy (CALD), the most severe manifestation of adrenoleukodystrophy (ALD), a rare metabolic disorder.

Xospata leads latest CHMP recommendations

The committee has recommended seven medicines for approval at its September 2019 meeting.

Tresiba lowers risk of hypos in type II diabetes

Tresiba significantly reduced the rate of severe hypoglycaemia by 80% and nocturnal symptomatic hypoglycaemia by 37%.

Sertraline improves anxiety, but ‘unlikely’ to treat depression

The findings support the prescription of SSRI antidepressants in a wider group of participants than previously thought.

‘New era’ of precision medicine for children with cancer

only 7% of children with targetable mutations were able to access the appropriate adult drug in a study.

Four Health, ARK top the PM Society Digital Awards 2019

The coveted Pharma Digital Partner award was won by Emma Prosser from MSD.